Cortical glucose metabolism is altered in aged transgenic Tg2576 mice that demonstrate Alzheimer plaque pathology.

作者: M. Bigl , J. Apelt , K. Eschrich , R. Schliebs

DOI: 10.1007/S00702-002-0772-X

关键词:

摘要: Alzheimer's disease is associated with markedly impaired cerebral glucose metabolism as detected by reduced cortical desoxyglucose utilization, altered activities of key glycolytic enzymes or densities transporter subtypes. To determine whether formation and/or deposition β-amyloid plays a role in the pathology metabolism, transgenic Tg2576 mice that overexpress Swedish mutation human amyloid precursor protein and demonstrate progressive, age-related hippocampal plaques, were used to study expression activity brain glycolysis (phosphofructokinase, PFK) glyconeogenesis (fructose1,6-bisphosphatase; FbPase). Quantitative RT-PCR revealed high levels both C- M-type PFK mRNA non-transgenic mouse cortex, whilst there was little L-type. In 24-month-old but not 7-, 13-, 17-month-old mice, copy number PFK-C significantly comparison littermates, while level other isoforms FbPase did differ between tissue samples. situ hybridization sections from aged plaque-associated neurons upregulation reactive astrocytes surrounding deposits. The decreased Western analysis accompanied enzyme comparisonto littermates. Our data impairment occurs only due long-lasting burden. This results reduction concomitant reactive, plaque-surrounding astrocytes.

参考文章(45)
S. Hoyer, Risk factors for Azheimer’s disease during aging. Impacts of glucose/energy metabolism Journal of Neural Transmission-supplement. ,vol. 54, pp. 187- 194 ,(1998) , 10.1007/978-3-7091-7508-8_18
Mark P. Mattson, Devin S. Gary, Sic L. Chan, Wenzhen Duan, Perturbed endoplasmic reticulum function, synaptic apoptosis and the pathogenesis of Alzheimer's disease Biochemical Society Symposia. ,vol. 67, pp. 151- 162 ,(2001) , 10.1042/BSS0670151
M. A. Pappolla, P. Bozner, Y. J. Chyan, R. A. Omar, M. A. Smith, G. Perry, K. Hsiao, Evidence of oxidative stress and in vivo neurotoxicity of β-amyloid in a transgenic mouse model of Alzheimer's disease: A chronic oxidative paradigm for testing antioxidant therapies in vivo American Journal of Pathology. ,vol. 152, pp. 871- 877 ,(1998)
W.C. Benzing, J.R. Wujek, E.K. Ward, D. Shaffer, K.H. Ashe, S.G. Younkin, K.R. Brunden, Evidence for glial-mediated inflammation in aged APPSW transgenic mice Neurobiology of Aging. ,vol. 20, pp. 581- 589 ,(1999) , 10.1016/S0197-4580(99)00065-2
Karen K Hsiao, David R Borchelt, Kristine Olson, Rosa Johannsdottir, Cheryl Kitt, Wael Yunis, Sherry Xu, Chris Eckman, Steven Younkin, Donald Price, Costantino Iadecola, H Brent Clark, George Carlson, None, Age-Related CNS Disorder and Early Death in Transgenic FVB/N Mice Overexpressing Alzheimer Amyloid Precursor Proteins Neuron. ,vol. 15, pp. 1203- 1218 ,(1995) , 10.1016/0896-6273(95)90107-8
W. Meier-Ruge, C. Bertoni-Freddari, P. Iwangoff, Changes in Brain Glucose Metabolism as a Key to the Pathogenesis of Alzheimer’s Disease Gerontology. ,vol. 40, pp. 246- 252 ,(1994) , 10.1159/000213592
CHRISTINE STURCHLER-PIERRAT, MATTHIAS STAUFENBIEL, Pathogenic mechanisms of Alzheimer's disease analyzed in the APP23 transgenic mouse model. Annals of the New York Academy of Sciences. ,vol. 920, pp. 134- 139 ,(2006) , 10.1111/J.1749-6632.2000.TB06915.X
Ute Krügel, Volker Bigl, Klaus Eschrich, Marina Bigl, Deafferentation of the septo-hippocampal pathway in rats as a model of the metabolic events in Alzheimer's disease. International Journal of Developmental Neuroscience. ,vol. 19, pp. 263- 277 ,(2001) , 10.1016/S0736-5748(01)00010-7